Huaren Pharmaceutical Co., Ltd. (SZSE: 300110)
Health Care · Pharmaceuticals · CN
CN¥2.86
-2.39% today · -20.6% 1Y
Huaren Pharmaceutical Co., Ltd. (SZSE: 300110) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $502.96M and employs 2,549 people.
Over the last twelve months the share price has lost 20.6%, trading between 2.41 and 3.66.
Tweenvest scores Huaren Pharmaceutical Co., Ltd. across four factors: quality 66/100, value 55/100, growth 0/100. Its strongest factor is quality.
300110 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $502.96M
- Revenue (TTM)
- $192.53M
- P/E
- —
- EPS
- -0.39
- Dividend yield
- —
- Beta (5Y)
- 0.27
- 52-week high
- CN¥3.66
- 52-week low
- CN¥2.41
- Avg volume (3M)
- —
- Shares outstanding
- 1.18B
- Employees
- 2,549
- Next earnings
- —
About Huaren Pharmaceutical Co., Ltd.
Huaren Pharmaceutical Co., Ltd. produces and sells non-PVC soft bag infusions in China. It offers doxofylline, levofloxacin hydrochloride, compound potassium hydrogen phosphate, and caffeine citrate, sodium chloride, glucose, glucose sodium potassium, chloride, compound sodium chloride, sodium lactate ringer, compound electrolyte, and sterilized water injections. The company also provides therapeutic infusion products for blood volume expansion, hemostasis, nervous and circulatory systems, anti-infection, anti-hepatitis, hepatitis adjuvant, anti-tumor, and sugar metabolism; and medical instruments, such as disposable incision retractors, disposable cannula puncture devices disposable specimen extractors, abdominal suction tubes, incision retractor protectors, iodine protective caps, slip pads, respiratory oscillation expectoration machines, protective mask cup types, protective and foldable disposable masks, and medical protective masks. In addition, it offers pharmaceutical packaging materials, including rubber stopper, carton, and membrane; rinsing fluid and API series products; and food and beverage, and medical skin care products. The company was founded in 1998 and is based in Qingdao, China.
- ISIN
- CNE100000SW1
- Founded
- 1998
- Listed since
- Aug 25, 2010
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,256.11 | +0.06% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.93 | +0.63% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.78 | +0.15% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.14 | +0.25% |
Figures last refreshed Aug 18, 2026.